Radiomics Quality Score 2.0: towards radiomics readiness levels and clinical translation for personalized medicine
P
Philippe Lambin
H
Henry C. Woodruff
S
Shruti Atul Mali
X
Xian Zhong
S
Sheng Kuang
E
Elizaveta Lavrova
H
Hamza Khan
K
Karim Lekadir
A
Alex Zwanenburg
J
Joseph Deasy
M
Maciej Bobowicz
L
Luis Marti-Bonmati
A
Andrew Maidment
M
Michel Dumontier
P
Paul E. Kinahan
J
J. Martijn Nobel
S
Sina Amirrajab
Z
Zohaib Salahuddin
Article Details
Journal
Nature Reviews Clinical Oncology
Volume / Issue
Vol. 22, Issue 11
Published
November 01, 2025
Pages
831-846
ISSN
1759-4774
Publisher
Springer Science and Business Media LLC
Journal Info
Nature Reviews Clinical Oncology
Springer Science and Business Media LLC
ISSN: 1759-4774 Q1 Medicine
Authors (18)
P
Philippe Lambin
H
Henry C. Woodruff
S
Shruti Atul Mali
X
Xian Zhong
S
Sheng Kuang
E
Elizaveta Lavrova
H
Hamza Khan
K
Karim Lekadir
A
Alex Zwanenburg
J
Joseph Deasy
M
Maciej Bobowicz
L
Luis Marti-Bonmati
A
Andrew Maidment
M
Michel Dumontier
P
Paul E. Kinahan
J
J. Martijn Nobel
S
Sina Amirrajab
Z
Zohaib Salahuddin
Related Articles from this Journal
Ibrutinib improves overall survival in patients with mantle cell lymphoma
Peter Sidaway
Jul 2026
10.1038/s41571-026-01166-7
First-line zanidatamab–chemotherapy with or without tislelizumab improves survival in advanced-stage HER2+ GEA
Diana Romero
Jul 2026
10.1038/s41571-026-01169-4
Clinical implementation of multi-cancer early detection tests: can we find a path forward?
Ariadna Tibau, Aaron S. Kesselheim
Jul 2026
10.1038/s41571-026-01158-7
Pan-RAS inhibitor daraxonrasib shows promise in pancreatic cancer
David Killock
Jul 2026
10.1038/s41571-026-01162-x
Liquid biopsy to inform adjuvant decisions during neoadjuvant chemotherapy — a full-circle moment for nasopharyngeal cancer
W. K. Jacky Lam, Brigette B. Y. Ma
Jul 2026
10.1038/s41571-026-01157-8